News
All News
Publications
All PublicationsPharmTechPharmTech Europe
Multimedia
All VideosAsk the ExpertBehind The HeadlinesDrug Digest VideosDrug Solutions Podcast
Conferences
Conference CoverageConference Listing
More
Webcasts
Resources
ICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPartnersPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksWhitepapers

Subscribe

  • News
  • Publications
  • Multimedia
  • Conferences
  • Webcasts
  • Resources
  • Subscribe
  • Analytics
    • Bio/Pharmaceutical Analysis Techniques
    • Laboratory Equipment and Instruments
  • Data and Artificial Intelligence
  • Dosage Forms
    • Solid/Semi-Solid Dosage
    • Specialty Dosage Drugs
    • Parenterals and Injectables
    • Inhalation Drugs
  • Drug Development
    • Intellectual Property and Patents
    • Process and Scaling
    • APIs and Excipients
    • Ingredients
    • Formulation and Drug Delivery
  • Manufacturing
    • Aseptic/Sterile Processing
    • Equipment
    • Process and Automation
    • Manufacturing, Parenterals and Injectables
    • Manufacturing, Biosimilars and Biobetters
    • Manufacturing, Inhalation Drugs
    • Manufacturing, Solid and Semi-Solid Dosage Drugs
    • Manufacturing, Cell Therapies
    • Manufacturing, Biologic Drugs
    • Supply Chain
    • Manufacturing, Gene Therapies
    • Packaging and Distribution
  • Outsourcing
    • Contract Research Services
    • Contract Analytical Services
    • Contract Development Services
    • Regulatory Consulting
    • Logistics and Distribution
    • Contract Manufacturing Services
  • Quality Systems
    • Ask the Expert
    • Quality Assurance/Quality Control
    • Regulatory Oversight and Compliance
Spotlight -
Analytics|
Dosage Forms|
Drug Development|
Manufacturing|
Outsourcing|
Quality Systems
Advertisement

Ananda Seneviratne

Advertisement

Ananda Seneviratne is principal scientist, Analytical and Formulation Development at Agensys, Inc., Santa Monica, CA.

Articles by Ananda Seneviratne

Characterization and Formulation Screening of mAb and ADCs by High-Throughput DLS

ByJihea Park,Aileen La,Ananda Seneviratne,Gaya Ratnaswamy
October 2nd 2015
Advertisement

Latest Updated Articles

  • Characterization and Formulation Screening of mAb and ADCs by  High-Throughput DLS
    Characterization and Formulation Screening of mAb and ADCs by High-Throughput DLS

    Published: October 2nd 2015 | Updated:



Advertisement
Advertisement

Trending on Pharmaceutical Technology

1

Nuclear Waste to Medicine: The UK’s Lead-212 Strategy for Cancer Care

2

New Targets for Clinical Trials in the European Union

3

Leveraging AI/ML to Reduce Risk in Drug Development: Part One

4

Shifting from Trial-and-Error to Rational Design Drives Efficiency in Pharmaceutical Formulation

5

Implications on SMA Care of High-Dose Nusinersen

  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us